Phase III Trials: It’s crunch time for these ASX health stocks
Several ASX-listed companies are making significant strides in their phase III clinical trials, the critical final stage ...
Yahoo Finance7d
Neuren Pharmaceuticals Limited's (ASX:NEU) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Neuren Pharmaceuticals' (ASX:NEU) stock is up by a considerable 13% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this ...
Armed robbery in Revesby7d
Neuren Partner Files Trofinetide EU Marketing Bid
Neuren Pharmaceuticals (ASX:NEU) has announced that its partner Acadia Pharmaceuticals has submitted a Marketing ...
Yahoo Finance7d
Neuren Pharmaceuticals Limited's (ASX:NEU) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Neuren Pharmaceuticals' (ASX:NEU) stock is up by a considerable 13% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance ...
Jefferies Sticks to Their Buy Rating for Neuren Pharmaceuticals Limited (NURPF)
Jefferies analyst David Stanton maintained a Buy rating on Neuren Pharmaceuticals Limited (NURPF – Research Report) on January 17 and set a ...
Listed drug development sector has several promising stories to tell this year
It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...
Why did this $1.4 billion ASX 200 healthcare stock just dive 9%?
The market didn't like what this stock had to say this morning... The post Why did this $1.4 billion ASX 200 healthcare stock just dive 9%? appeared first on The Motley Fool Australia.
Why CAR Group, Myer, Neuren, and Yancoal shares are falling today
These shares are having a tough time on hump day. But why? The post Why CAR Group, Myer, Neuren, and Yancoal shares are falling today appeared first on The Motley Fool Australia.